First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 166.41 USD 1.06% Market Closed
Updated: Apr 20, 2024

Abbvie Inc
Net Income (Common)

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Net Income (Common) Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$4.8B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$5.7B
CAGR 3-Years
258%
CAGR 5-Years
1%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
25%
Seagen Inc
NASDAQ:SGEN
Net Income (Common)
$-750.2m
CAGR 3-Years
N/A
CAGR 5-Years
-36%
CAGR 10-Years
-29%

See Also

What is Abbvie Inc's Net Income (Common)?
Net Income (Common)
4.8B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Net Income (Common) amounts to 4.8B USD.

What is Abbvie Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
2%

Over the last year, the Net Income (Common) growth was -59%. The average annual Net Income (Common) growth rates for Abbvie Inc have been 2% over the past three years , -3% over the past five years , and 2% over the past ten years .